Clinical Trials Logo

Clinical Trial Summary

This phase II study is evaluating the activity of Pemetrexed in patients diagnosed with low risk Gestational Trophoblastic Tumor (GTT) that have failed prior treatment.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00190918
Study type Interventional
Source Eli Lilly and Company
Contact
Status Completed
Phase Phase 2
Start date July 2006
Completion date July 2007

See also
  Status Clinical Trial Phase
Completed NCT02374411 - Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients N/A
Completed NCT00377520 - A Trial for Patients With Advanced/Recurrent Endometrial Cancer Phase 2
Recruiting NCT04063072 - ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy. N/A
Terminated NCT01969396 - Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology N/A
Terminated NCT00669422 - ChemoFx® PRO - A Post-Market Data Collection Study N/A
Recruiting NCT01564264 - Sentinel Node Biopsy in Endometrial Cancer N/A
Completed NCT00231855 - Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers Phase 2
Completed NCT04679675 - Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial N/A
Completed NCT04351139 - Impact of the COVID-19 Pandemic in Gynecological Oncology
Completed NCT05004623 - Early Feasibility Study of the "Easy Light" Fluorecence Imaging System N/A
Completed NCT00112307 - Magnetic Resonance Imaging Guided Gynecologic Brachytherapy N/A
Completed NCT02454036 - Biobehavioral Intervention in Gynecologic Oncology Patients Phase 2
Completed NCT00188578 - Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2) Phase 1/Phase 2
Active, not recruiting NCT03951415 - Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer Phase 2
Completed NCT01654458 - A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer N/A
Completed NCT00050440 - Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma Phase 2
Completed NCT00250783 - Pre-Clinical Models in Gynecological Tumors A Tissue Repository
Recruiting NCT03624712 - Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
Completed NCT00628901 - A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) Phase 4
Completed NCT00090389 - Acupuncture for Women's Health Conditions Phase 1